HEALTHLINX LIMITED (HTX.AX)
From ValueWiki
Business Description from asx.com.au: The Company is principally dedicated to rapid low-risk cost effective drug discovery via an innovative process involving proteins. Whilst initially specializing in cardiovascular disease the Company now plans to move into other biomarkers and diagnostics as a result of the acquisition of HealthLinx Pty Ltd in February 2006.[1]
|
|
Company Analysis
You can add your own information here - just click the blue edit tab. Or view examples at the Start a new article page.
The edit window has shortcut and help links if you need them.[2] Be bold!
News Feed
Leadership
- HEALTHLINX LIMITED Executive Information
- HEALTHLINX LIMITED Directors / Senior Management[1]
Mr Alan Graham Watman (Chairman) Mr Nick Gatsios (Managing Director) Mr Gregory Edward Rice (Non Exec. Director) Mr Mario Guiseppe Pennisi (Non Exec. Director)
Risks
This section needs content! Click the blue edit link (to the right) to contribute.
Research Links
- HEALTHLINX LIMITED Profile
- HEALTHLINX LIMITED Fundamentals
- HEALTHLINX LIMITED Technical Analysis
- HEALTHLINX LIMITED Contact Information[1]
- Website: http://www.healthlinx.com.au
- Address: c/- Grant Thornton , Level 17 , 383 Kent Street , SYDNEY , NSW, AUSTRALIA, 2000
- Phone: (03) 9639 6349
- Fax: (03) 9639 7855
- Share Registry: COMPUTERSHARE INVESTOR SERVICES PTY LIMITED YARRA FALLS , 452 JOHNSTON STREET , ABBOTSFORD , VIC, AUSTRALIA, 3067
- Share Registry Phone: 1300 787 171 (BKR ONLY)
- HEALTHLINX LIMITED Message Boards
Notes
- ↑ 1.0 1.1 1.2 http://www.asx.com.au/asx/research/CompanyInfoSearchResults.jsp?searchBy=asxCode&allinfo=on&asxCode=HTX ASX.com.au
- ↑ This is a sample reference.
